These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9218913

  • 1. Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical response.
    Jones RN, Dudley MN.
    Diagn Microbiol Infect Dis; 1997 May; 28(1):5-18. PubMed ID: 9218913
    [Abstract] [Full Text] [Related]

  • 2. Ampicillin-sulbactam susceptibility testing criteria.
    Barry A, Pfaller M, Fuchs P, Gerlach E, Hardy D, McLaughlin J.
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):469-72. PubMed ID: 8359171
    [Abstract] [Full Text] [Related]

  • 3. Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.
    Bradford PA, Sanders CC.
    Antimicrob Agents Chemother; 1993 Feb; 37(2):251-9. PubMed ID: 8452355
    [Abstract] [Full Text] [Related]

  • 4. Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.
    Jones RN, Barry AL.
    J Clin Microbiol; 1987 Oct; 25(10):1920-5. PubMed ID: 3117843
    [Abstract] [Full Text] [Related]

  • 5. Proposed changes in interpretive criteria and potency of ampicillin and ampicillin-sulbactam disks for susceptibility tests.
    Barry AL, Jones RN.
    J Clin Microbiol; 1988 Apr; 26(4):750-4. PubMed ID: 3130390
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam.
    Mortensen JE, LaRocco M, Himes SL, Inderlied C, Daly JA, Campos JM, Mendelman PM.
    Diagn Microbiol Infect Dis; 1990 Apr; 13(4):341-4. PubMed ID: 2076596
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
    Varaldo PE, Ripa S, Nicoletti G, Covelli I, Satta G, Carlone N, Fontana R.
    Chemotherapy; 1990 Apr; 36(2):141-6. PubMed ID: 2178890
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.
    Barry AL, Jones RN.
    J Clin Microbiol; 1988 Jan; 26(1):13-7. PubMed ID: 3343304
    [Abstract] [Full Text] [Related]

  • 14. Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks.
    Barry AL, Jones RN, Thornsberry C.
    J Clin Microbiol; 1984 Feb; 19(2):134-9. PubMed ID: 6321543
    [Abstract] [Full Text] [Related]

  • 15. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
    Villar HE, Jugo MB, Fernández-Lausi A, Farinati AE.
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
    [Abstract] [Full Text] [Related]

  • 16. Comparative activity of cefoxitin, ampicillin/sulbactam, and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumoniae.
    Shungu DL, Ponticas S, Gill CJ.
    Clin Ther; 1989 May; 11(3):315-8. PubMed ID: 2663161
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.
    Bradford PA, Sanders CC.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):394-400. PubMed ID: 1605604
    [Abstract] [Full Text] [Related]

  • 20. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.